InspireMD, Inc. (NSPR) is a publicly traded Healthcare sector company. As of September 21, 2026, NSPR trades at $0.76 with a market cap of $35.94M and a P/E ratio of -1.24. NSPR moved +0.00% today. Year to date, NSPR is -56.89%; over the trailing twelve months it is -68.29%. Its 52-week range spans $0.63 to $3.80. Analyst consensus is strong buy with an average price target of $3.33. Rallies surfaces NSPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NSPR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.76 |
| Market Cap | $35.94M |
| P/E Ratio | -1.24 |
| EPS | $-0.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.80 |
| 52-Week Low | $0.63 |
| Volume | 49.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $10.84M |
| Net Income | $-52.48M |
| Gross Margin | 18.05% |
3 analysts cover NSPR: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.33.